<DOC>
	<DOCNO>NCT02890966</DOCNO>
	<brief_summary>The objective study assess tolerance , pharmacokinetic pharmacodynamic property multiple dose adminstration SHR4640 healthy volunteer .</brief_summary>
	<brief_title>Multiple Dose Study SHR4640 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<criteria>1 . Age 18 55 , male ; 2 . Body weight≥50 , BMI:1925kg/m2 ; 3.4 mg/dL≤Screening serum urate level≤7 mg/dL ; 4.Medically stable base physical examination , laboratory result , vital sign measurement , 12lead electrocardiogram , abdomen Bultrasound Chest Xray examination screen . 1 . Serum creatinine＞upper limit normal ( ULN ) ; 2 . Alanine aminotransferase and/or Aspartate aminotransferase＞2×ULN , total bilirubin＞1.5×ULN , glutamyltransferase＞3×ULN ; 3 . History hyperuricemia gout ; 4 . History suspicion kidney stone ; 5 . Positive result hepatitis B surface antigen , hepatitis C antibody , HIV antibody , syphilis antibody test .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>SHR4640 pharmacokinetics pharmacodynamics</keyword>
</DOC>